MTHFR and blood coagulation disease: Specifically, out of all patients with coagulopathy, 23% had anticardiolipin antibodies, while equally distributed were the presence of lupus anticoagulant, MTHFR gene mutation, antithrombin III and protein C and S deficiency (15.4% each).